Status:
COMPLETED
The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Pelvic Ring Fractures
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
Pelvic ring fractures in the geriatric population are a rising problem for surgeons in industrialized countries. Many of these low-energy fractures are treated nonoperatively; however, pain is a signi...
Detailed Description
Baseline: Treatment group will be prescribed 200IU of ISC daily for a period of 3 months. The control group will not be prescribed calcitonin. Participants will complete research only Iowa pelvis scor...
Eligibility Criteria
Inclusion
- •Males or females over the age of 65 who sustain isolated pelvic ring injuries via a low-energy mechanism
Exclusion
- An open pelvic ring fracture
- Concomitant acetabular fracture
- They are on ISC prior to enrollment
- Allergic or have contraindications to calcitonin or salmon
- Sustain other injuries in their spine or lower extremities
- Unwilling to participate in the study
- Nonambulatory at baseline
- Neurologic deficit associated with the pelvic ring injury
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03812991
Start Date
July 1 2019
End Date
February 28 2023
Last Update
June 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Health System
Columbia, Missouri, United States, 65212